Latest News and Press Releases

Seattle, WA, May 02, 2023 (GLOBE NEWSWIRE) -- Discuss, the leading purpose-built video platform for turning in-depth feedback into insights, announced Genie, a new layer of generative artificial...

DALLAS, May 02, 2023 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a global leader of access, optical and cloud-controlled software defined solutions, today announced that Misty Kawecki, CFO of DZS, has...

SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern...

A total of 652 children, ages 2 to 5, were enrolled in the studyTopline data expected in the third quarterAtopic dermatitis (AD) affects approximately 26 million adults and children in the United...

Seattle, May 02, 2023 (GLOBE NEWSWIRE) -- The winners of Fast Company’s 2023 World Changing Ideas Awards were announced today, honoring sustainable designs, innovative products, bold social...

HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...

Miami, FL, May 02, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...

Revenue of $4.0 billion, an increase of 2% with organic growth of 5%Operating income of $972 million, an increase of 9%Operating margin of 24.2%, an increase of 150 bpsGAAP EPS of $2.33, an increase...

ZKN-013 is in development for potential treatment of recessive dystrophic and junctional epidermolysis bullosa (RDEB and JEB) and Familial Adenomatous Polyposis (FAP) ZKN-013 is Eloxx’s first drug...

VANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) -- VERSES AI Inc. (NEO:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”) is pleased to announce its participation as an Emerging Sponsor at...